Global cognitive effects of second-generation antidepressants in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials

Amidfar, 2017, Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study, J. Clin. Pharm. Therapeut., 42, 44, 10.1111/jcpt.12469 An, 2017, The effect of escitalopram on mood and cognition in depressive alzheimer's disease subjects, J Alzheimers Dis, 55, 727, 10.3233/JAD-160225 Arbus, 2010, Antidepressant use in Alzheimer's disease patients: results of the REAL.FR cohort, Int. Psychogeriatr., 22, 120, 10.1017/S1041610209990780 Arvanitakis, 2019, Diagnosis and management of dementia: review, JAMA, 322, 1589, 10.1001/jama.2019.4782 Banerjee, 2011, Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial, Lancet, 378, 403, 10.1016/S0140-6736(11)60830-1 Banerjee, 2021, Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial, Lancet (London, England), 398, 1487, 10.1016/S0140-6736(21)01210-1 Barnhart, 2004, SSRI-induced apathy syndrome: a clinical review, J. Psychiatr. Pract., 10, 196, 10.1097/00131746-200405000-00010 Bartels, 2018, Impact of SSRI therapy on risk of conversion from mild cognitive impairment to alzheimer's dementia in individuals with previous depression, Am. J. Psychiatr., 175, 232, 10.1176/appi.ajp.2017.17040404 Camargos, 2014, Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study, Am. J. Geriatr. Psychiatr. : official journal of the American Association for Geriatric Psychiatry, 22, 1565, 10.1016/j.jagp.2013.12.174 Chan, 2020, Treatment-Resistant depression enhances risks of dementia and alzheimer's disease: a nationwide longitudinal study, J. Affect. Disord., 274, 806, 10.1016/j.jad.2020.05.150 Chi, 2014, Depression in Alzheimer's disease: epidemiology, mechanisms, and management, J Alzheimers Dis, 42, 739, 10.3233/JAD-140324 Choe, 2016, Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease, Int. J. Geriatr. Psychiatr., 31, 731, 10.1002/gps.4384 Cirrito, 2020, Effect of escitalopram on Abeta levels and plaque load in an Alzheimer mouse model, Neurology, 95, e2666, 10.1212/WNL.0000000000010733 Clerici, 2012, Memantine effects on behaviour in moderately severe to severe Alzheimer's disease: a post-marketing surveillance study, Neurol. Sci., 33, 23, 10.1007/s10072-011-0618-0 Dudas, 2018, Antidepressants for treating depression in dementia, Cochrane Database Syst. Rev., 8 Dutcher, 2014, Effect of medications on physical function and cognition in nursing home residents with dementia, J. Am. Geriatr. Soc., 62, 1046, 10.1111/jgs.12838 Feighner, 1999, Mechanism of action of antidepressant medications, J. Clin. Psychiatr., 60, 4 Finkel, 2004, A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil, Int. J. Geriatr. Psychiatr., 19, 9, 10.1002/gps.998 Galts, 2019, Depression in neurodegenerative diseases: common mechanisms and current treatment options, Neurosci. Biobehav. Rev., 102, 56, 10.1016/j.neubiorev.2019.04.002 Gaynes, 2009, What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression, Psychiatr. Serv., 60, 1439, 10.1176/ps.2009.60.11.1439 Graipaspong, 2016, Cholinesterase inhibitors and behavioral & psychological symptoms of alzheimer's disease, J. Med. Assoc. Thai., 99, 433 Hedges, 1994, Statistical considerations Henry, 2011, Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia, a literature review of evidence, Am J Alzheimers Dis Other Demen, 26, 169, 10.1177/1533317511402051 Higgins, 2008, 187 Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 Hoehn-Saric, 1990, Apathy and indifference in patients on fluvoxamine and fluoxetine, J. Clin. Psychopharmacol., 10, 343, 10.1097/00004714-199010000-00007 Howard, 2011, Determining the minimum clinically important differences for outcomes in the DOMINO trial, Int. J. Geriatr. Psychiatr., 26, 812, 10.1002/gps.2607 Hsu, 2021, Efficacy of serotonergic antidepressant treatment for the neuropsychiatric symptoms and agitation in dementia: a systematic review and meta-analysis, Ageing Res. Rev., 69, 10.1016/j.arr.2021.101362 Jamieson, 2019, Depression related cerebral pathology and its relationship with cognitive functioning: a systematic review, J. Affect. Disord., 250, 410, 10.1016/j.jad.2019.03.042 Lavretsky, 2020, A randomized double-blind placebo-controlled trial of combined escitalopram and memantine for older adults with major depression and subjective memory complaints, Am. J. Geriatr. Psychiatr., 28, 178, 10.1016/j.jagp.2019.08.011 Lozupone, 2018, Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorder, Expet Opin. Pharmacother., 19, 823, 10.1080/14656566.2018.1471136 Lyketsos, 2003, Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS, Arch. Gen. Psychiatr., 60, 737, 10.1001/archpsyc.60.7.737 Ma, 2017, Fluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe/PSEN1dE9 double transgenic Alzheimer's disease mice, Oncotarget, 8, 27676, 10.18632/oncotarget.15398 Maier, 2020, Bupropion for the treatment of apathy in alzheimer disease: a randomized clinical trial, JAMA Netw. Open, 3, 10.1001/jamanetworkopen.2020.6027 Moretti, 2002, Depression and Alzheimer's disease: symptom or comorbidity?, Am. J. Alzheimer's Dis. Other Dementias, 17, 338, 10.1177/153331750201700607 Mowla, 2007, Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial, J. Clin. Psychopharmacol., 27, 484, 10.1097/jcp.0b013e31814b98c1 Mowla, 2007, Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment?: a double-blind, placebo-controlled, clinical trial, J. Clin. Psychopharmacol., 27, 67, 10.1097/JCP.0b013e31802e0002 Padala, 2012, Reversal of SSRI-associated apathy syndrome by discontinuation of therapy, Ann. Pharmacother., 46, 10.1345/aph.1Q656 Palmer, 1987, Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease, Brain Res., 401, 231, 10.1016/0006-8993(87)91408-9 Petracca, 2001, A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease, Int. Psychogeriatr., 13, 233, 10.1017/S104161020100761X Porsteinsson, 2014, Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial, JAMA, 311, 682, 10.1001/jama.2014.93 Quinn, 2005, Comparing rat's to human's age: how old is my rat in people years?, Nutrition, 21, 775, 10.1016/j.nut.2005.04.002 Rashidi-Ranjbar, 2020, Frontal-executive and corticolimbic structural brain circuitry in older people with remitted depression, mild cognitive impairment, Alzheimer's dementia, and normal cognition, Neuropsychopharmacology, 45, 1567, 10.1038/s41386-020-0715-y Reddy, 2021, Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer's disease, Hum. Mol. Genet., 30, 789, 10.1093/hmg/ddab091 Reynolds, 2011, Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy, Arch. Gen. Psychiatr., 68, 51, 10.1001/archgenpsychiatry.2010.184 Rodriguez, 2012, The serotonergic system in ageing and Alzheimer's disease, Prog. Neurobiol., 99, 15, 10.1016/j.pneurobio.2012.06.010 Rosenberg, 2012, The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease, Int. J. Geriatr. Psychiatr., 27, 1248, 10.1002/gps.3769 Scoralick, 2017, Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 17, 89, 10.1111/psyg.12191 Serretti, 2007, Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients, Mol. Psychiatr., 12, 247, 10.1038/sj.mp.4001926 Taylor, 2021, Preliminary evidence that cortical amyloid burden predicts poor response to antidepressant medication treatment in cognitively intact individuals with late-life depression, Am. J. Geriatr. Psychiatr., 29, 448, 10.1016/j.jagp.2020.09.019 Teri, 2000, Treatment of agitation in AD: a randomized, placebo-controlled clinical trial, Neurology, 55, 1271, 10.1212/WNL.55.9.1271 Torrisi, 2019, Fluoxetine and vortioxetine reverse depressive-like phenotype and memory deficits induced by abeta1-42 oligomers in mice: a key role of transforming growth factor-beta1, Front. Pharmacol., 10, 693, 10.3389/fphar.2019.00693 Tsai, 2010, Effects of BDNF polymorphisms on antidepressant action, Psychiatry Investig, 7, 236, 10.4306/pi.2010.7.4.236 Weintraub, 2010, Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes, Am. J. Geriatr. Psychiatr. : official journal of the American Association for Geriatric Psychiatry, 18, 332, 10.1097/JGP.0b013e3181cc0333 Zhao, 2016, The prevalence of neuropsychiatric symptoms in Alzheimer's disease: systematic review and meta-analysis, J. Affect. Disord., 190, 264, 10.1016/j.jad.2015.09.069 Zhou, 2019, Fluoxetine delays the cognitive function decline and synaptic changes in a transgenic mouse model of early Alzheimer's disease, J. Comp. Neurol., 527, 1378, 10.1002/cne.24616 Zhou, 2019, Effect of memantine combined with citalopram on cognition of BPSD and moderate Alzheimer's disease: a clinical trial, Exp. Ther. Med., 17, 1625